ORDER A TEST Log In Contact Us

Resources

Webinars

Filter By
  • image description
    02/28/2024

    Unlocking the power of RNA in drug development

    Hear insights from industry leaders on understanding, leveraging, and validating RNA in the drug development process.

    Speakers: Calvin Chao, MD
    SVP of Medical Affairs, Tempus

    Brian Rini, MD, FASCO
    Chief of Clinical Trials, Hematology & Oncology, Vanderbilt University Medical Center

    Scott Haake, MD, PhD
    Assistant Professor of Medicine, Hematology & Oncology, Vanderbilt University Medical Center

    Nilofer Azad, MD
    Professor of Oncology Co-Director, Developmental Therapeutics Program/Phase I Program Co-Leader, Cancer Genetics and Epigenetics, Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University

    Watch replay
  • image description
    10/17/2023

    Impact of multimodal data in translational science

    In this panel session we spoke to Translational Scientists who have been utilizing multi-modal insights in their daily work and discussed what new information can come to light by utilizing these tools.

    Speakers: Iker Huerga
    EVP, Life Science Strategy & RWD, Tempus

    Jonathan Dry
    VP, Scientific Discovery, Tempus

    Charles Lin, PhD
    SVP, TRN Mapping, KronosBio

    Pedram Razavi, MD, PhD
    Director, Breast Translational Program and Molecular Tumor Board, Memorial Sloan Kettering Cancer Center

    Watch replay
  • image description
    08/18/2023

    An analysis on the utility of liquid biopsy (LBx) throughout clinical development

    Listen to industry leaders discuss longitudinal endpoints for disease progression, the evolving role of liquid biopsy within drug development, and the value of methylation in combination with liquid biopsy.

    Speakers: Nike Beaubier, MD
    Senior Vice President, Life Science Pathology, Tempus

    Ezra Cohen, MD
    Chief Medical Officer of Oncology, Tempus

    Michael Yasiejko
    General Manager and Executive Vice President, Tempus

    Watch replay
  • image description
    05/23/2023

    Accelerate clinical trial enrollment and site activation

    Learn how TriHealth uses the TIME network to identify trial subjects and rapidly activate new clinical trials within its oncology portfolio within an average of ~10 business days.

    Speakers: Amy Gordon Franzen
    SVP, Trials Business, Tempus

    James F Maher, MD
    Oncologist, TriHealth

    Jason Claes, MBA, MSM, GRCRA
    Clinical Research Manager, TriHealth

    Watch replay
  • image description
    05/18/2023

    Tempus’ FDA approval and insights on the use of companion diagnostics in clinical development

    Tempus has recently announced the PMA approval for xT CDx, our solid tumor CDx and 648 gene panel.

    Speakers: Elaine Katrivanos
    VP, Regulatory Affairs, Tempus

    Lauren Silvis
    SVP, External Affairs, Tempus

    Kate Sasser
    Chief Scientific Officer, Tempus

    Watch replay
  • image description
    03/30/2023

    NGS in advanced breast cancer: exploring recent clinical advancements

    Learn more about breast cancer management with NGS. We explore the potential utility of complementary solid tumor and liquid biopsy testing in informing treatment decisions, as well as patient management strategies in the post CDK4/6 inhibitor therapy setting.

    Speakers: Calvin Chao, MD
    SVP of Medical Affairs, Tempus

    Cynthia Ma, MD, PhD
    Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center

    Massimo Cristofanilli, MD, FACP
    Chief, Breast Medical Oncology, Sandra Edward Meyer Cancer Center at Weill Cornell Medicine

    Watch replay
  • image description
    02/16/2023

    Increasing PTS using multimodal data

    Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.

    Speakers: Iker Huerga
    SVP, Life Sciences Strategy, Tempus

    Leora Horn, MD
    Global Clinical Head for Lung Cancer & Lung Cancer Strategy, AstraZeneca

    Watch replay
  • image description
    12/06/2022

    Multimodal data drives biomarker innovation

    We spoke with Gilead experts to learn how the company uses multimodal data to achieve early successes in translational biomarker research and discovery.

    Speakers: Ryan Fukushima
    Chief Operating Officer, Tempus

    Scott Patterson, PhD
    Vice President of Biomarker Sciences, Gilead Sciences, Inc.

    Shahed Iqbal, PhD
    Senior Director and Head of Molecular Epidemiology, Biomarker Sciences, Gilead Sciences, Inc.

    Watch replay
  • image description
    06/14/2022

    The next evolution in drug development

    We spoke with Janssen’s Dr. Najat Khan to find out how the company is applying advanced AI algorithms to RWD – with groundbreaking results.

    Speakers: Najat Khan, Ph.D., Chief Data Science Officer and Global Head, Strategy and Operations, Janssen Research & Development; Ryan Fukushima, Chief Operating Officer, Tempus

    Watch replay
  • image description
    09/30/2021

    Discover novel targets and applications with Tempus Explore

    Speakers: Jay Baum, PhD, Leap Therapeutics; Adam Koch, PhD, Tempus

    Watch replay